Micro RNA-Mediated Epigenetic Regulation in Hormonal Pathways: Insights into Thyroid Cancer Progression
DOI:
https://doi.org/10.70749/ijbr.v3i7.1843Keywords:
Thyroid Cancer, Epigenetics, MicroRNAs (miRNA), Hormonal SignalingAbstract
Thyroid cancer is the most prevalent endocrine malignancy, and its prevalence is continuously increasing globally. Thyroid cancer is a complicated disease that is impacted by environmental, genetic, and epigenetic factors. Among these, epigenetics, which are heritable variations in gene expression that do not include changes in the DNA sequence, has drawn much interest. The physiology and pathology of the thyroid gland depend heavily on hormonal pathways, especially those involving thyroid hormones. It has been demonstrated that their dysregulation promotes the development of tumors and the progression of cancer. MicroRNAs (miRNA or miRNAs) are key regulators of these epigenetic modifications. They modulate gene expression through chromatin remodeling, DNA methylation, and histone modifications, thereby influencing hormonal signaling pathways critical to thyroid physiology and pathology. Dysregulation of miRNA can disrupt thyroid hormone signaling, affect the expression of hormone-responsive genes and receptors, and contribute to tumor initiation, progression, and metastasis. Recent studies highlight the interplay between thyroid hormone signaling and miRNA-mediated epigenetic regulation in thyroid cancer. Understanding these molecular mechanisms is crucial for the development of novel diagnostic biomarkers and targeted therapeutic strategies.
Downloads
References
Acibucu, F., Dökmetaş, H., Tutar, Y., Elagoz, Ş., & Kilicli, F. (2014). Correlations between the expression levels of micro-rna146b, 221, 222 and p27Kip1 protein mRNA and the Clinicopathologic parameters in papillary thyroid cancers. Experimental and Clinical Endocrinology & Diabetes, 122(03), 137-143.
https://doi.org/10.1055/s-0034-1367025
Acuña-Ruiz, A., Carrasco-López, C., & Santisteban, P. (2023). Genomic and epigenomic profile of thyroid cancer. Best Practice & Research Clinical Endocrinology & Metabolism, 37(1), 101656.
https://doi.org/10.1016/j.beem.2022.101656
Aranda, A. (2021). MicroRNAs and thyroid hormone action. Molecular and Cellular Endocrinology, 525, 111175.
https://doi.org/10.1016/j.mce.2021.111175
Armos, R., Bojtor, B., Papp, M., Illyes, I., Lengyel, B., Kiss, A., Szili, B., Tobias, B., Balla, B., Piko, H., Illes, A., Putz, Z., Kiss, A., Toth, E., Takacs, I., Kosa, J. P., & Lakatos, P. (2024). MicroRNA profiling in papillary thyroid cancer. International Journal of Molecular Sciences, 25(17), 9362.
https://doi.org/10.3390/ijms25179362
Bhattacharya, S., Mahato, R. K., Singh, S., Bhatti, G. K., Mastana, S. S., & Bhatti, J. S. (2023). Advances and challenges in thyroid cancer: The interplay of genetic modulators, targeted therapies, and AI-driven approaches. Life Sciences, 332, 122110.
https://doi.org/10.1016/j.lfs.2023.122110
Bible, K. C., Kebebew, E., Brierley, J., Brito, J. P., Cabanillas, M. E., Clark, T. J., Di Cristofano, A., Foote, R., Giordano, T., Kasperbauer, J., Newbold, K., Nikiforov, Y. E., Randolph, G., Rosenthal, M. S., Sawka, A. M., Shah, M., Shaha, A., Smallridge, R., & Wong-Clark, C. K. (2021). 2021 American thyroid association guidelines for management of patients with anaplastic thyroid cancer. Thyroid, 31(3), 337-386.
https://doi.org/10.1089/thy.2020.0944
Bielak, C., Arya, A., & Savill, S. (2023). Circulating microRNA as potential diagnostic and prognostic biomarkers of well-differentiated thyroid cancer: A review article. Cancer Biomarkers, 36(3), 193-205.
https://doi.org/10.3233/cbm-210504
Bolf, E. L., Gillis, N. E., Davidson, C. D., Rodriguez, P. D., Cozzens, L., Tomczak, J. A., Frietze, S., & Carr, F. E. (2020). Thyroid hormone receptor beta induces a tumor-suppressive program in anaplastic thyroid cancer. Molecular Cancer Research, 18(10), 1443-1452.
https://doi.org/10.1158/1541-7786.mcr-20-0282
Brent, G. A. (2012). Mechanisms of thyroid hormone action. Journal of Clinical Investigation, 122(9), 3035-3043.
https://doi.org/10.1172/jci60047
Cabanillas, M. E., McFadden, D. G., & Durante, C. (2016). Thyroid cancer. The Lancet, 388(10061), 2783-2795.
https://doi.org/10.1016/s0140-6736(16)30172-6
Casula, S., & Bianco, A. C. (2012). Thyroid hormone Deiodinases and cancer. Frontiers in Endocrinology, 3.
https://doi.org/10.3389/fendo.2012.00074
Chen, L., Xie, T., Lei, Q., Gu, Y., & Sun, C. (2024). A review of complex hormone regulation in thyroid cancer: Novel insights beyond the hypothalamus–pituitary–thyroid axis. Frontiers in Endocrinology, 15.
https://doi.org/10.3389/fendo.2024.1419913
Chen, Z., Li, S., Subramaniam, S., Shyy, J. Y., & Chien, S. (2017). Epigenetic regulation: A new frontier for biomedical engineers. Annual Review of Biomedical Engineering, 19(1), 195-219.
https://doi.org/10.1146/annurev-bioeng-071516-044720
Davalos, V., Moutinho, C., Villanueva, A., Boque, R., Silva, P., Carneiro, F., & Esteller, M. (2011). Dynamic epigenetic regulation of the microrna-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis. Oncogene, 31(16), 2062-2074.
https://doi.org/10.1038/onc.2011.383
Davis, P. J., Leonard, J. L., & Davis, F. B. (2008). Mechanisms of nongenomic actions of thyroid hormone. Frontiers in Neuroendocrinology, 29(2), 211-218.
https://doi.org/10.1016/j.yfrne.2007.09.003
De la Chapelle, A., & Jazdzewski, K. (2011). MicroRNAs in thyroid cancer. The Journal of Clinical Endocrinology & Metabolism, 96(11), 3326-3336.
https://doi.org/10.1210/jc.2011-1004
Denaro, N., Romanò, R., Alfieri, S., Dolci, A., Licitra, L., Nuzzolese, I., Ghidini, M., Bareggi, C., Bertaglia, V., Solinas, C., & Garrone, O. (2023). The tumor microenvironment and the estrogen loop in thyroid cancer. Cancers, 15(9), 2458.
https://doi.org/10.3390/cancers15092458
Dong, W., Zhang, H., Li, J., Guan, H., He, L., Wang, Z., Shan, Z., & Teng, W. (2013). Estrogen induces metastatic potential of papillary thyroid cancer cells through estrogen receptor α and β. International Journal of Endocrinology, 2013, 1-6.
https://doi.org/10.1155/2013/941568
Ely, K., Bischoff, L., & Weiss, V. (2018). Wnt signaling in thyroid homeostasis and carcinogenesis. Genes, 9(4), 204.
https://doi.org/10.3390/genes9040204
Fan, D., Liu, S. Y., Van Hasselt, C. A., Vlantis, A. C., Ng, E. K., Zhang, H., Dong, Y., Ng, S. K., Chu, R., Chan, A. B., Du, J., Wei, W., Liu, X., Liu, Z., Xing, M., & Chen, G. G. (2015). Estrogen receptor α induces Prosurvival autophagy in papillary thyroid cancer via stimulating reactive oxygen species and Extracellular signal regulated kinases. The Journal of Clinical Endocrinology & Metabolism, 100(4), E561-E571.
https://doi.org/10.1210/jc.2014-3257
Faria, C. C., Peixoto, M. S., Carvalho, D. P., & Fortunato, R. S. (2019). The emerging role of estrogens in thyroid redox homeostasis and carcinogenesis. Oxidative Medicine and Cellular Longevity, 2019, 1-13.
https://doi.org/10.1155/2019/2514312
Ferraz, C. (2018). Can current molecular tests help in the diagnosis of indeterminate thyroid nodule FNAB? Archives of Endocrinology and Metabolism, 62(6), 576-584.
https://doi.org/10.20945/2359-3997000000081
Foster, J. R., Tinwell, H., & Melching-Kollmuss, S. (2021). A review of species differences in the control of, and response to, chemical-induced thyroid hormone perturbations leading to thyroid cancer. Archives of Toxicology, 95(3), 807-836.
https://doi.org/10.1007/s00204-020-02961-6
Frías-Lasserre, D., & Villagra, C. A. (2017). The importance of ncRNAs as epigenetic mechanisms in phenotypic variation and organic evolution. Frontiers in Microbiology, 8.
https://doi.org/10.3389/fmicb.2017.02483
Geng, A., Wu, T., Cai, C., Song, W., Wang, J., Yu, Q. C., & Zeng, Y. A. (2020). Author response: A novel function of R-spondin1 in regulating estrogen receptor expression independent of Wnt/β-catenin signaling.
https://doi.org/10.7554/elife.56434.sa2
Geng, X., Li, Y., Sun, Y., Cao, L., & Song, Z. (2024). Microrna-181b-5p facilitates thyroid cancer growth via targeting programmed cell death 4. Molecular Biotechnology, 66(5), 1154-1164.
https://doi.org/10.1007/s12033-023-01013-5
Ghafouri-Fard, S., Shirvani-Farsani, Z., & Taheri, M. (2020). The role of microRNAs in the pathogenesis of thyroid cancer. Non-coding RNA Research, 5(3), 88-98.
https://doi.org/10.1016/j.ncrna.2020.06.001
Goemann, I. M., Romitti, M., Meyer, E. L., Wajner, S. M., & Maia, A. L. (2017). Role of thyroid hormones in the neoplastic process: An overview. Endocrine-Related Cancer, 24(11), R367-R385.
https://doi.org/10.1530/erc-17-0192
Golbabapour, S., Abdulla, M. A., & Hajrezaei, M. (2011). A concise review on epigenetic regulation: Insight into molecular mechanisms. International Journal of Molecular Sciences, 12(12), 8661-8694.
https://doi.org/10.3390/ijms12128661
Gómez‐Pérez, A. M., Cornejo Pareja, I. M., García Alemán, J., Coín Aragüez, L., Sebastián Ochoa, A., Alcaide Torres, J., Molina Vega, M., Clu Fernández, C., Mancha Doblas, I., & Tinahones, F. J. (2019). New molecular biomarkers in differentiated thyroid carcinoma: Impact of Mir‐146, Mir‐221 and Mir‐222 levels in the evolution of the disease. Clinical Endocrinology, 91(1), 187-194.
https://doi.org/10.1111/cen.13972
Gong, Z., Yang, S., Wei, M., Vlantis, A. C., Chan, J. Y., Van Hasselt, C. A., Li, D., Zeng, X., Xue, L., Tong, M. C., & Chen, G. G. (2022). The Isoforms of estrogen receptor Alpha and beta in thyroid cancer. Frontiers in Oncology, 12.
https://doi.org/10.3389/fonc.2022.916804
Gu, Y., Zhang, X., Li, Y., Shi, J., Cui, H., Ren, Y., Liu, S., Qiao, Y., Cheng, Y., & Liu, Y. (2023). Mir-204-5p-targeted AP1S2 is necessary for papillary thyroid carcinoma. Molecular and Cellular Endocrinology, 574, 111993.
https://doi.org/10.1016/j.mce.2023.111993
Guo, K., Wang, J., Shu, L., & Zhou, G. (2021). Mir-200c promotes papillary thyroid cancer cell proliferation, migration, and invasion by downregulating PTEN. Tissue and Cell, 73, 101647.
https://doi.org/10.1016/j.tice.2021.101647
Han, T., Hur, K., Cho, H., & Ban, H. S. (2020). Epigenetic associations between lncRNA/circRNA and miRNA in hepatocellular carcinoma. Cancers, 12(9), 2622.
https://doi.org/10.3390/cancers12092622
Hima, S., & Sreeja, S. (2015). Modulatory role of 17β‐estradiol in the tumor microenvironment of thyroid cancer. IUBMB Life, 68(2), 85-96.
https://doi.org/10.1002/iub.1462
Hwang, E., Doolittle, W. K., Zhu, Y. J., Zhu, X., Zhao, L., Yu, Y., & Cheng, S. (2023). Thyroid hormone receptor α1: A novel regulator of thyroid cancer cell differentiation. Oncogene, 42(41), 3075-3086.
https://doi.org/10.1038/s41388-023-02815-2
Jin, S., Yang, Y., & Bao, W. (2018). Signaling pathways in thyroid cancer. Vitamins and Hormones, 501-515.
https://doi.org/10.1016/bs.vh.2017.05.002
Kalfert, D., Ludvikova, M., Pesta, M., Ludvik, J., Dostalova, L., & Kholová, I. (2020). Multifunctional roles of Mir-34a in cancer: A review with the emphasis on head and neck squamous cell carcinoma and thyroid cancer with clinical implications. Diagnostics, 10(8), 563.
https://doi.org/10.3390/diagnostics10080563
Kim, M. J., Kim, S., Choi, S., Lee, I., Moon, M. K., Choi, K., Park, Y. J., Cho, Y. H., Kwon, Y. M., Yoo, J., Cheon, G. J., & Park, J. (2021). Association of exposure to polycyclic aromatic hydrocarbons and heavy metals with thyroid hormones in general adult population and potential mechanisms. Science of The Total Environment, 762, 144227.
https://doi.org/10.1016/j.scitotenv.2020.144227
Kondrotienė, A., Daukša, A., Pamedytytė, D., Kazokaitė, M., Žvirblienė, A., Daukšienė, D., Simanavičienė, V., Klimaitė, R., Golubickaitė, I., Stakaitis, R., Šarauskas, V., Verkauskienė, R., & Žilaitienė, B. (2020). Plasma-derived mirna-222 as a candidate marker for papillary thyroid cancer. International Journal of Molecular Sciences, 21(17), 6445.
https://doi.org/10.3390/ijms21176445
Kumar, S., Gonzalez, E. A., Rameshwar, P., & Etchegaray, J. (2020). Non-coding RNAs as mediators of epigenetic changes in malignancies. Cancers, 12(12), 3657.
https://doi.org/10.3390/cancers12123657
Li, D., Yang, Y., Li, Y., Zhu, X., & Li, Z. (2021). Epigenetic regulation of gene expression in response to environmental exposures: From bench to model. Science of The Total Environment, 776, 145998.
https://doi.org/10.1016/j.scitotenv.2021.145998
Li, H., & Wu, P. (2024). Epigenetics in thyroid cancer: A bibliometric analysis. Endocrine Connections, 13(9).
https://doi.org/10.1530/ec-24-0087
Li, N., Liu, X., Han, L., Zhou, R., Yan, J., Zhao, G., & Liu, L. (2019). Expression of mirna-146b-5p in patients with thyroid cancer in combination with Hashimoto's disease and its clinical significance. Oncology Letters, 17(6), 4871-4876.
https://doi.org/10.3892/ol.2019.10173
Liang, L., Zheng, X., Hu, M., Cui, Y., Zhong, Q., Wang, S., & Huang, F. (2018). Mirna-221/222 in thyroid cancer: A meta-analysis. Clinica Chimica Acta, 484, 284-292.
https://doi.org/10.1016/j.cca.2018.06.012
Lin, H., Glinsky, G. V., Mousa, S. A., & Davis, P. J. (2015). Thyroid hormone and anti-apoptosis in tumor cells. Oncotarget, 6(17), 14735-14743.
https://doi.org/10.18632/oncotarget.4023
Liu, J., Chen, G., Meng, X., Liu, Z., & Dong, S. (2014). Serum levels of sex hormones and expression of their receptors in thyroid tissue in female patients with various types of thyroid neoplasms. Pathology - Research and Practice, 210(12), 830-835.
https://doi.org/10.1016/j.prp.2014.09.002
Liu, J., Xu, T., Ma, L., & Chang, W. (2021). Signal pathway of estrogen and estrogen receptor in the development of thyroid cancer. Frontiers in Oncology, 11.
https://doi.org/10.3389/fonc.2021.593479
Liu, Y., Yeh, C., & Lin, K. (2020). Reply to comments: “Molecular functions of thyroid hormone signaling in regulation of cancer progression and anti-apoptosis” Int. J. Mol. Sci., 2019, 20, 4986. International Journal of Molecular Sciences, 21(10), 3554.
https://doi.org/10.3390/ijms21103554
Macvanin, M., Gluvic, Z., Radovanovic, J., Essack, M., Gao, X., & Isenovic, E. R. (2023). New insights on the cardiovascular effects of IGF-1. Frontiers in Endocrinology, 14.
https://doi.org/10.3389/fendo.2023.1142644
Moeller, L. C., & Führer, D. (2013). Thyroid hormone, thyroid hormone receptors, and cancer: A clinical perspective. Endocrine-Related Cancer, 20(2), R19-R29.
https://doi.org/10.1530/erc-12-0219
Morales, S., Monzo, M., & Navarro, A. (2017). Epigenetic regulation mechanisms of microRNA expression. Biomolecular Concepts, 8(5-6), 203-212.
https://doi.org/10.1515/bmc-2017-0024
Mousa, S. A., Glinsky, G. V., Lin, H., Ashur-Fabian, O., Hercbergs, A., Keating, K. A., & Davis, P. J. (2018). Contributions of thyroid hormone to cancer metastasis. Biomedicines, 6(3), 89.
https://doi.org/10.3390/biomedicines6030089
Mousa, S. A., Hercbergs, A., Lin, H., Keating, K. A., & Davis, P. J. (2021). Actions of thyroid hormones on thyroid cancers. Frontiers in Endocrinology, 12.
https://doi.org/10.3389/fendo.2021.691736
Mullur, R., Liu, Y., & Brent, G. A. (2014). Thyroid hormone regulation of metabolism. Physiological Reviews, 94(2), 355-382.
https://doi.org/10.1152/physrev.00030.2013
Park, J., Kim, S., Jeon, S., Jung, C., & Kim, Y. (2021). MicroRNA profile for diagnostic and prognostic biomarkers in thyroid cancer. Cancers, 13(4), 632.
https://doi.org/10.3390/cancers13040632
Perdas, E., Stawski, R., Nowak, D., & Zubrzycka, M. (2016). The role of miRNA in papillary thyroid cancer in the context of miRNA let-7 family. International Journal of Molecular Sciences, 17(6), 909.
https://doi.org/10.3390/ijms17060909
Petranović Ovčariček, P., Campennì, A., Ruggeri, R. M., Kreissl, M. C., Verburg, F. A., Vrachimis, A., Tuncel, M., & Giovanella, L. (2024). Higher thyroid hormone levels and cancer. Vitamins and Hormones.
https://doi.org/10.1016/bs.vh.2024.08.002
Pishkari, S., Paryan, M., Hashemi, M., Baldini, E., & Mohammadi-Yeganeh, S. (2017). The role of microRNAs in different types of thyroid carcinoma: A comprehensive analysis to find new miRNA supplementary therapies. Journal of Endocrinological Investigation, 41(3), 269-283.
https://doi.org/10.1007/s40618-017-0735-6
Rahbari, R., Zhang, L., & Kebebew, E. (2010). Thyroid cancer gender disparity. Future Oncology, 6(11), 1771-1779.
https://doi.org/10.2217/fon.10.127
Ramírez-Moya, J., Wert-Lamas, L., & Santisteban, P. (2018). Microrna-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN. Oncogene, 37(25), 3369-3383.
https://doi.org/10.1038/s41388-017-0088-9
Reid, G., Kao, S. C., Pavlakis, N., Brahmbhatt, H., MacDiarmid, J., Clarke, S., Boyer, M., & Van Zandwijk, N. (2016). Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer. Epigenomics, 8(8), 1079-1085.
https://doi.org/10.2217/epi-2016-0035
Ricci, C., Salvemini, A., Dalmiglio, C., Castagna, M. G., & Cantara, S. (2023). From circulating tumor cells to Mirna: New challenges in the diagnosis and prognosis of medullary thyroid cancer. Cancers, 15(15), 4009.
https://doi.org/10.3390/cancers15154009
Rubio, G. A., Catanuto, P., Glassberg, M. K., Lew, J. I., & Elliot, S. J. (2018). Estrogen receptor subtype expression and regulation is altered in papillary thyroid cancer after menopause. Surgery, 163(1), 143-149.
https://doi.org/10.1016/j.surg.2017.04.031
Samsonov, R., Burdakov, V., Shtam, T., Radzhabovа, Z., Vasilyev, D., Tsyrlina, E., Titov, S., Ivanov, M., Berstein, L., Filatov, M., Kolesnikov, N., Gil-Henn, H., & Malek, A. (2016). Plasma exosomal Mir-21 and Mir-181a differentiates follicular from papillary thyroid cancer. Tumor Biology, 37(9), 12011-12021.
https://doi.org/10.1007/s13277-016-5065-3
Sarropoulou, E., & Fernández, I. (2023). Epigenetic regulation of gene expression by Noncoding RNAs. Epigenetics in Aquaculture, 65-93.
https://doi.org/10.1002/9781119821946.ch3
Shinderman-Maman, E., Cohen, K., Weingarten, C., Nabriski, D., Twito, O., Baraf, L., Hercbergs, A., Davis, P. J., Werner, H., Ellis, M., & Ashur-Fabian, O. (2015). The thyroid hormone-αvβ3 integrin axis in ovarian cancer: Regulation of gene transcription and MAPK-dependent proliferation. Oncogene, 35(15), 1977-1987.
https://doi.org/10.1038/onc.2015.262
Singh, B. K., Sinha, R. A., Ohba, K., & Yen, P. M. (2017). Role of thyroid hormone in hepatic gene regulation, chromatin remodeling, and autophagy. Molecular and Cellular Endocrinology, 458, 160-168.
https://doi.org/10.1016/j.mce.2017.02.018
Sousa, D. P., & Conde, J. (2022). Gold Nanoconjugates for miRNA modulation in cancer therapy: From miRNA silencing to miRNA mimics. ACS Materials Au, 2(6), 626-640.
https://doi.org/10.1021/acsmaterialsau.2c00042
Sun, C. X., Liu, B. J., Su, Y., Shi, G. W., Wang, Y., & Chi, J. F. (2021). Mir-181a promotes cell proliferation and migration through targeting KLF15 in papillary thyroid cancer. Clinical and Translational Oncology, 24(1), 66-75.
https://doi.org/10.1007/s12094-021-02670-1
Sun, W., Jiang, C., Liu, Q., Wang, N., Huang, R., Jiang, G., & Yang, Y. (2024). Exosomal noncoding RNAs: Decoding their role in thyroid cancer progression. Frontiers in Endocrinology, 15.
https://doi.org/10.3389/fendo.2024.1337226
Tafani, M., De Santis, E., Coppola, L., Perrone, G. A., Carnevale, I., Russo, A., Pucci, B., Carpi, A., Bizzarri, M., & Russo, M. A. (2014). Bridging hypoxia, inflammation and estrogen receptors in thyroid cancer progression. Biomedicine & Pharmacotherapy, 68(1), 1-5.
https://doi.org/10.1016/j.biopha.2013.10.013
Arif, K. M., Elliott, E. K., Haupt, L. M., & Griffiths, L. R. (2020). Regulatory mechanisms of epigenetic miRNA relationships in human cancer and potential as therapeutic targets. Cancers, 12(10), 2922.
https://doi.org/10.3390/cancers12102922
Toden, S., Zumwalt, T. J., & Goel, A. (2021). Non-coding RNAs and potential therapeutic targeting in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1875(1), 188491.
https://doi.org/10.1016/j.bbcan.2020.188491
Vannucchi, G., De Leo, S., Perrino, M., Rossi, S., Tosi, D., Cirello, V., Colombo, C., Bulfamante, G., Vicentini, L., & Fugazzola, L. (2015). Impact of estrogen and progesterone receptor expression on the clinical and molecular features of papillary thyroid cancer. European Journal of Endocrinology, 173(1), 29-36.
https://doi.org/10.1530/eje-15-0054
Vasudevan, N., Ogawa, S., & Pfaff, D. (2002). Estrogen and thyroid hormone receptor interactions: Physiological flexibility by molecular specificity. Physiological Reviews, 82(4), 923-944.
https://doi.org/10.1152/physrev.00014.2002
Wade, S. L., Langer, L. F., Ward, J. M., & Archer, T. K. (2015). Mirna-mediated regulation of the SWI/SNF chromatin remodeling complex controls Pluripotency and endodermal differentiation in human ESCs. Stem Cells, 33(10), 2925-2935.
https://doi.org/10.1002/stem.2084
Wang, H., Li, S., Shi, J., Feng, C., Wang, Y., & Zhang, F. (2023). Unbalanced bidirectional causal association between thyroid cancer and ER-positive breast cancer: Should we recommend screening for thyroid cancer in breast cancer patients? BMC Genomics, 24(1).
https://doi.org/10.1186/s12864-023-09854-9
Wang, M., Li, J., Zuo, Z., Ren, C., Tang, T., Long, C., Gong, Y., Ye, F., Wang, Z., & Huang, J. (2020). Long non-coding RNA DIO3OS/let-7d/NF-κb2 axis regulates cells proliferation and metastasis of thyroid cancer cells. Journal of Cell Communication and Signaling, 15(2), 237-250.
https://doi.org/10.1007/s12079-020-00589-w
Wang, N., Li, Y., Wei, J., Pu, J., Liu, R., Yang, Q., Guan, H., Shi, B., Hou, P., & Ji, M. (2019). Tbx1 functions as a tumor suppressor in thyroid cancer through inhibiting the activities of the pi3k/Akt and mapk/Erk pathways. Thyroid, 29(3), 378-394.
https://doi.org/10.1089/thy.2018.0312
Wu, Y., Lin, Z., Li, C., Lin, X., Shan, S., Guo, B., Zheng, M., Li, F., Yuan, L., & Li, Z. (2023). Epigenetic regulation in metabolic diseases: Mechanisms and advances in clinical study. Signal Transduction and Targeted Therapy, 8(1).
https://doi.org/10.1038/s41392-023-01333-7
Xing, M. (2013). Molecular pathogenesis and mechanisms of thyroid cancer. Nature Reviews Cancer, 13(3), 184-199.
https://doi.org/10.1038/nrc3431
Xu, F., Zheng, L., Chen, K., Wang, R., Yi, D., Jiang, C., Liu, Z., SHI, X., & Sang, J. (2023). Serum sex hormones correlate with pathological features of papillary thyroid cancer. Endocrine, 84(1), 148-154.
https://doi.org/10.1007/s12020-023-03554-w
Yao, Y., Xu, P., Ying, T., Wang, Y., Wang, X., Shu, L., Mo, Z., Chen, Z., Wang, X., Wang, W., Teng, L., & Lou, X. (2022). Integrative analysis of DNA methylation and gene expression identified follicular thyroid cancer-specific diagnostic biomarkers. Frontiers in Endocrinology, 12.
https://doi.org/10.3389/fendo.2021.736068
Zaballos, M. A., & Santisteban, P. (2017). Key signaling pathways in thyroid cancer. Journal of Endocrinology, 235(2), R43-R61.
https://doi.org/10.1530/joe-17-0266
Zabegina, L., Nazarova, I., Knyazeva, M., Nikiforova, N., Slyusarenko, M., Titov, S., Vasilyev, D., Sleptsov, I., & Malek, A. (2020). MiRNA let-7 from TPO(+) Extracellular vesicles is a potential marker for a differential diagnosis of follicular thyroid nodules. Cells, 9(8), 1917.
https://doi.org/10.3390/cells9081917
ZEMBSKA, A., JAWIARCZYK-PRZYBYŁOWSKA, A., WOJTCZAK, B., & BOLANOWSKI, M. (2018). MicroRNA expression in the progression and aggressiveness of papillary thyroid carcinoma. Anticancer Research, 39(1), 33-40.
https://doi.org/10.21873/anticanres.13077
Zhang, H., Duan, H., Wang, S., Liu, Y., Ding, G., & Lin, R. (2022). Epigenetic signature associated with thyroid cancer progression and metastasis. Seminars in Cancer Biology, 83, 261-268.
https://doi.org/10.1016/j.semcancer.2021.03.026
Zhang, K., Wang, J., He, Z., Qiu, X., Sa, R., & Chen, L. (2023). Epigenetic targets and their inhibitors in thyroid cancer treatment. Pharmaceuticals, 16(4), 559.
https://doi.org/10.3390/ph16040559
ZHANG, Z., LIU, Z., REN, W., YE, X., & ZHANG, Y. (2012). The Mir-200 family regulates the epithelial-mesenchymal transition induced by EGF/EGFR in anaplastic thyroid cancer cells. International Journal of Molecular Medicine, 30(4), 856-862.
https://doi.org/10.3892/ijmm.2012.1059
Zhu, L., Deng, H., Hu, J., Huang, S., Xiong, J., & Deng, J. (2018). The promising role of Mir-296 in human cancer. Pathology - Research and Practice, 214(12), 1915-1922.
https://doi.org/10.1016/j.prp.2018.09.026
Zhu, X., & Cheng, S. (2017). Epigenetic modifications: Novel therapeutic approach for thyroid cancer. Endocrinology and Metabolism, 32(3), 326.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
